Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346812 · ClinicalTrials.gov registry record · NA
Brassica Intake and Isothiocyanate Absorption
A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02346812: Completed NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
NCT02346812 is a NA study that has completed, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02346812, a NA study, has completed, sponsored by USDA Beltsville Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Healthy individuals (n=18) will participate in 2 controlled-feeding study periods that are 3 weeks each in length: 1) Control diet 2) Brassica diet. The control diet will consist of typical American foods and will be free of Brassica vegetables and free of glucosinolates and isothiocyanates. The Brassica diet will contain the control diet plus glucosinolate/isothiocyanate treatment foods. There will be a break of 3 weeks in between study periods. Blood, urine, and fecal samples will be collected at the end of each study period. Eligible participants will be selected based on genotype for glutathione S-transferase (GST), which has been shown to influence the potential protective role of dietary Brassicas. Half the participants (n=9) will be GSTM1-positive individuals and half (n=9) will have the GSTM1-null genotype.
Primary Outcome
At the end of each study period, total ITC equivalents will be measured in blood and urine over a 24-hour period.
Interventions
- OTHER Controlled diet without brassica vegetables
- OTHER Controlled diet with brassica vegetables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02346812 record still lists
NCT02346812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Controlled diet without brassica vegetables is the first listed.
NCT02346812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02346812 about?
NCT02346812 is a clinical study titled "Brassica Intake and Isothiocyanate Absorption". Healthy individuals (n=18) will participate in 2 controlled-feeding study periods that are 3 weeks each in length: 1) Control diet 2) Brassica diet. The control diet will consist of typical American foods and will be free of Brassica vegetables and free of glucosinolates and isothiocyanates. The Bra...
What is the current status of trial NCT02346812?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-01. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02346812?
The interventions under investigation include: Controlled diet without brassica vegetables (OTHER), Controlled diet with brassica vegetables (OTHER).
Who is sponsoring clinical trial NCT02346812?
This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02346812's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia